Literature DB >> 15592898

Tetracycline and its analogues as inhibitors of amyloid fibrils: searching for a geometrical pharmacophore by theoretical investigation of their conformational behavior in aqueous solution.

Ugo Cosentino1, M Rosaria Varí, A A Gloria Saracino, Demetrio Pitea, Giorgio Moro, Mario Salmona.   

Abstract

Tetracycline (TC) and its derivatives have recently been proposed as a new class of antagonists in prion diseases as they prevent the aggregation of prion protein peptides and their acquisition of protease resistance in vitro and in vivo. Looking for relationships between conformational flexibility and biological activity, we searched for a geometrical pharmacophore by investigating, in aqueous solution, the conformational behavior of 15 TCs in both the zwitterionic and the anionic forms. For TC similar conformational flexibility was found for the two forms and two main conformational families were detected, an extended and a folded conformation characterized by different intramolecular hydrogen-bond networks. On comparing the Molecular Mechanics results with the ab initio ones and the experimental evidence, it can be seen that the conformational behavior of TC is reasonably well predicted by the MM2 force field, whereas the conformational energies provided by the Amber force field are unreliable. The conformational analysis of the other TC derivatives was then performed by the MM2 force field. As a result, their conformational behavior was similar to that observed for TC itself. Despite the hydronaphthacene moiety's conformational flexibility, no geometrical pharmacophore was found among the TCs, i.e. properties other than geometrical ones should play a crucial role in determining their anti-fibrillogenic ability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15592898     DOI: 10.1007/s00894-004-0213-x

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  26 in total

1.  Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use.

Authors:  F Stuer-Lauridsen; M Birkved; L P Hansen; H C Lützhøft; B Halling-Sørensen
Journal:  Chemosphere       Date:  2000-04       Impact factor: 7.086

2.  A proton nuclear magnetic resonance study of the site of metal binding in tetracycline.

Authors:  D E Williamson; G W Everett
Journal:  J Am Chem Soc       Date:  1975-04-30       Impact factor: 15.419

3.  IsoStar: a library of information about nonbonded interactions.

Authors:  I J Bruno; J C Cole; J P Lommerse; R S Rowland; R Taylor; M L Verdonk
Journal:  J Comput Aided Mol Des       Date:  1997-11       Impact factor: 3.686

4.  Circular dichroism and solution conformation of the tetracycline antibiotics.

Authors:  L A Mitscher; A C Bonacci; T D Sokoloski
Journal:  Tetrahedron Lett       Date:  1968-10       Impact factor: 2.415

5.  Identification of a protein that purifies with the scrapie prion.

Authors:  D C Bolton; M P McKinley; S B Prusiner
Journal:  Science       Date:  1982-12-24       Impact factor: 47.728

6.  Conformational analysis of the anhydrotetracycline molecule: a toxic decomposition product of tetracycline.

Authors:  H F Dos Santos; W B De Almeida; M C Zerner
Journal:  J Pharm Sci       Date:  1998-02       Impact factor: 3.534

7.  Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.

Authors:  I Chopra; M Roberts
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

8.  Doxycycline determination in human serum and urine by high-performance liquid chromatography.

Authors:  A P De Leenheer; H J Nelis
Journal:  J Pharm Sci       Date:  1979-08       Impact factor: 3.534

9.  Neurotoxicity of a prion protein fragment.

Authors:  G Forloni; N Angeretti; R Chiesa; E Monzani; M Salmona; O Bugiani; F Tagliavini
Journal:  Nature       Date:  1993-04-08       Impact factor: 49.962

10.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

View more
  6 in total

1.  Computational approaches to shed light on molecular mechanisms in biological processes.

Authors:  Giorgio Moro; Laura Bonati; Maurizio Bruschi; Ugo Cosentino; Luca De Gioia; Pier Carlo Fantucci; Alessandro Pandini; Elena Papaleo; Demetrio Pitea; Gloria A A Saracino; Giuseppe Zampella
Journal:  Theor Chem Acc       Date:  2007-05-01       Impact factor: 1.702

2.  The structure of 5a,6-anhydrotetracycline and its Mg2+ complexes in aqueous solution.

Authors:  Olaf G Othersen; Harald Lanig; Timothy Clark
Journal:  J Mol Model       Date:  2006-05-03       Impact factor: 1.810

3.  The anti-fibrillogenic activity of tetracyclines on PrP 106-126: a 3D-QSAR study.

Authors:  Ugo Cosentino; Demetrio Pitea; Giorgio Moro; Gloria A A Saracino; Pietro Caria; Rosaria M Varì; Laura Colombo; Gianluigi Forloni; Fabrizio Tagliavini; Mario Salmona
Journal:  J Mol Model       Date:  2008-07-16       Impact factor: 1.810

4.  The efficacy of tetracyclines in peripheral and intracerebral prion infection.

Authors:  Ada De Luigi; Laura Colombo; Luisa Diomede; Raffaella Capobianco; Michela Mangieri; Claudia Miccolo; Lucia Limido; Gianluigi Forloni; Fabrizio Tagliavini; Mario Salmona
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240

Review 5.  Classification Framework and Chemical Biology of Tetracycline-Structure-Based Drugs.

Authors:  Domenico Fuoco
Journal:  Antibiotics (Basel)       Date:  2012-06-12

Review 6.  Targeting Amyloid Aggregation: An Overview of Strategies and Mechanisms.

Authors:  Sofia Giorgetti; Claudio Greco; Paolo Tortora; Francesco Antonio Aprile
Journal:  Int J Mol Sci       Date:  2018-09-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.